Childhood Cancer

Oncology
2
Pipeline Programs
3
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
2
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
2100%

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Kazia Therapeutics
Kazia TherapeuticsAustralia - Sydney
1 program
1
PaxalisibPhase 1/2Small Molecule
Bristol Myers Squibb
1 program
1
PaxalisibPhase 1/2Small Molecule1 trial
Active Trials
NCT06208657Recruiting90Est. Dec 2035

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
2028
2029
2030
2031
Bristol Myers SquibbPaxalisib

Clinical Trials (1)

Total enrollment: 90 patients across 1 trials

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

Start: Jul 2024Est. completion: Dec 203590 patients
Phase 1/2Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 90 patients
3 companies competing in this space